$PLRX PLIANT THERAPEUTICS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PLIANT THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PLIANT THERAPEUTICS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in PLIANT THERAPEUTICS, INC. for free.
IRS Number: 474272481
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PLRX
Company Address: 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO 94080
Phone number: 650-481-6770
PLIANT THERAPEUTICS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 30.23 | 22 | 665 | 137,080 | 137.1 K to 137.1 K (-0.02 %) |
| Jun 22 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 29.43 | 3,728 | 109,718 | 137,102 | 140.8 K to 137.1 K (-2.65 %) |
| Jun 22 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 28.62 | 8,750 | 250,438 | 140,830 | 149.6 K to 140.8 K (-5.85 %) |
| May 28 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | M | 2.08 | 4,500 | 9,360 | 12,979 | |
| May 28 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | M | 2.08 | 4,500 | 9,360 | 125,246 | 120.7 K to 125.2 K (+3.73 %) |
| Apr 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | M | 2.08 | 6,000 | 12,480 | 337,380 | |
| Apr 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 30.33 | 3,500 | 106,161 | 456,817 | 460.3 K to 456.8 K (-0.76 %) |
| Apr 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | M | 2.08 | 6,000 | 12,480 | 54,840 | 48.8 K to 54.8 K (+12.29 %) |
| Mar 19 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 39.78 | 1,135 | 45,150 | 149,580 | 150.7 K to 149.6 K (-0.75 %) |
| Mar 19 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 39.38 | 11,365 | 447,528 | 150,715 | 162.1 K to 150.7 K (-7.01 %) |
| Mar 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 39.69 | 178 | 7,064 | 460,317 | 460.5 K to 460.3 K (-0.04 %) |
| Mar 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 38.75 | 2,000 | 77,501 | 460,495 | 462.5 K to 460.5 K (-0.43 %) |
| Mar 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 38.03 | 1,322 | 50,270 | 462,495 | 463.8 K to 462.5 K (-0.29 %) |
| Mar 05 2021 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | M | 2.08 | 20,000 | 41,600 | 170,097 | |
| Mar 05 2021 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | M | 2.08 | 20,000 | 41,600 | 47,621 | 27.6 K to 47.6 K (+72.41 %) |